382 related articles for article (PubMed ID: 25763777)
1. Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration.
van Eersel J; Stevens CH; Przybyla M; Gladbach A; Stefanoska K; Chan CK; Ong WY; Hodges JR; Sutherland GT; Kril JJ; Abramowski D; Staufenbiel M; Halliday GM; Ittner LM
Neuropathol Appl Neurobiol; 2015 Dec; 41(7):906-25. PubMed ID: 25763777
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammatory Gene Regulation, Mitochondrial Function, Oxidative Stress, and Brain Lipid Modifications With Disease Progression in Tau P301S Transgenic Mice as a Model of Frontotemporal Lobar Degeneration-Tau.
López-González I; Aso E; Carmona M; Armand-Ugon M; Blanco R; Naudí A; Cabré R; Portero-Otin M; Pamplona R; Ferrer I
J Neuropathol Exp Neurol; 2015 Oct; 74(10):975-99. PubMed ID: 26360374
[TBL] [Abstract][Full Text] [Related]
3. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
[TBL] [Abstract][Full Text] [Related]
4. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
[TBL] [Abstract][Full Text] [Related]
5. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
6. The behavioural phenotype of 14-month-old female TAU58/2 transgenic mice.
Kreilaus F; Masanetz R; Watt G; Przybyla M; Ittner A; Ittner L; Karl T
Behav Brain Res; 2021 Jan; 397():112943. PubMed ID: 33017638
[TBL] [Abstract][Full Text] [Related]
7. Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
Przybyla M; van Eersel J; van Hummel A; van der Hoven J; Sabale M; Harasta A; Müller J; Gajwani M; Prikas E; Mueller T; Stevens CH; Power J; Housley GD; Karl T; Kassiou M; Ke YD; Ittner A; Ittner LM
Brain; 2020 Jun; 143(6):1889-1904. PubMed ID: 32375177
[TBL] [Abstract][Full Text] [Related]
8. Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology.
Koga S; Zhou X; Murakami A; Fernandez De Castro C; Baker MC; Rademakers R; Dickson DW
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12778. PubMed ID: 34823271
[TBL] [Abstract][Full Text] [Related]
9. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.
Thal DR; von Arnim CA; Griffin WS; Mrak RE; Walker L; Attems J; Arzberger T
J Neural Transm (Vienna); 2015 Jul; 122(7):1007-18. PubMed ID: 25556950
[TBL] [Abstract][Full Text] [Related]
10. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
[TBL] [Abstract][Full Text] [Related]
11. Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration.
Melis V; Zabke C; Stamer K; Magbagbeolu M; Schwab K; Marschall P; Veh RW; Bachmann S; Deiana S; Moreau PH; Davidson K; Harrington KA; Rickard JE; Horsley D; Garman R; Mazurkiewicz M; Niewiadomska G; Wischik CM; Harrington CR; Riedel G; Theuring F
Cell Mol Life Sci; 2015 Jun; 72(11):2199-222. PubMed ID: 25523019
[TBL] [Abstract][Full Text] [Related]
12. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein.
Taniguchi S; McDonagh AM; Pickering-Brown SM; Umeda Y; Iwatsubo T; Hasegawa M; Mann DM
Neuropathol Appl Neurobiol; 2004 Feb; 30(1):1-18. PubMed ID: 14720172
[TBL] [Abstract][Full Text] [Related]
13. CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.
Ke YD; Chan G; Stefanoska K; Au C; Bi M; Müller J; Przybyla M; Feiten A; Prikas E; Halliday GM; Piguet O; Kiernan MC; Kassiou M; Hodges JR; Loy CT; Mattick JS; Ittner A; Kril JJ; Sutherland GT; Ittner LM
J Biol Chem; 2019 Sep; 294(38):14149-14162. PubMed ID: 31366728
[TBL] [Abstract][Full Text] [Related]
14. β-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregates.
Woo JA; Liu T; Fang CC; Castaño MA; Kee T; Yrigoin K; Yan Y; Cazzaro S; Matlack J; Wang X; Zhao X; Kang DE; Liggett SB
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):5006-5015. PubMed ID: 32071246
[TBL] [Abstract][Full Text] [Related]
15. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
[TBL] [Abstract][Full Text] [Related]
16. Synaptic changes in frontotemporal lobar degeneration: correlation with MAPT haplotype and APOE genotype.
Connelly SJ; Mukaetova-Ladinska EB; Abdul-All Z; Alves da Silva J; Brayne C; Honer WG; Mann DM
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):366-80. PubMed ID: 21073671
[TBL] [Abstract][Full Text] [Related]
17. Impulsivity, decreased social exploration, and executive dysfunction in a mouse model of frontotemporal dementia.
Van der Jeugd A; Vermaercke B; Halliday GM; Staufenbiel M; Götz J
Neurobiol Learn Mem; 2016 Apr; 130():34-43. PubMed ID: 26827932
[TBL] [Abstract][Full Text] [Related]
18. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
[TBL] [Abstract][Full Text] [Related]
20. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.
Woollacott IOC; Toomey CE; Strand C; Courtney R; Benson BC; Rohrer JD; Lashley T
J Neuroinflammation; 2020 Aug; 17(1):234. PubMed ID: 32778130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
